We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TPB:NYSETurning Point Brands, Inc. Analysis

Data as of 2026-06-13 - not real-time

$82.55

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Turning Point Brands posted an impressive earnings surprise of +11.8% and a revenue beat of +7.0% in Q1 2026, driven by a 16.8% YoY revenue growth and solid margins (gross 56.8%, operating 10.3%). The stock is trading at $82.55, below its 20‑day ($86.36) and 50‑day ($83.29) moving averages, with the 200‑day SMA still at $98.47, indicating a longer‑term downtrend. Technical signals are mixed: the RSI sits near the neutral 44.6, while a bearish MACD histogram (-0.79) and a price hovering just above the identified support of $79.15 suggest limited upside in the near term, though volume is trending upward and volatility remains high at 45.7% (30‑day).
Fundamentally, TPB carries a high forward PE of 28.9 and a price‑to‑book of 4.37**,** yet the DCF‑derived fair value of $10.89 and an analyst‑derived upside of ~57% point to a potential mispricing. The company maintains a modest dividend yield of 0.38% with a low payout ratio (10%), supporting dividend sustainability despite negative free cash flow. Debt levels are elevated (debt‑to‑equity 80.4%) but cash reserves provide a cushion. Recent analyst upgrades to “Buy” and a median price target of $130 reinforce a bullish outlook, while regulatory and sector‑specific risks remain medium to high.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Earnings and revenue beats
  • Bearish MACD and price below short‑term SMAs
  • Increasing volume but high short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Analyst upgrade to Buy and $130 median price target
  • Strong revenue growth and healthy operating margins
  • Low payout ratio suggesting sustainable dividend

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Elevated debt‑to‑equity ratio
  • Regulatory headwinds inherent to the tobacco industry
  • Consistent brand presence and diversified product mix

Key Metrics & Analysis

Financial Health

Revenue Growth16.80%
Profit Margin11.53%
P/E Ratio28.3
ROE22.52%
ROA8.27%
Debt/Equity80.44
P/B Ratio4.4
Op. Cash Flow$17.7M
Free Cash Flow$-16831750

Technical Analysis

TrendNeutral
RSI44.6
Support$79.15
Resistance$92.57
MA 20$86.36
MA 50$83.29
MA 200$98.47
MACDBearish
VolumeIncreasing
Fear & Greed Index89.86

Valuation

Fair Value$10.89
Target Price$130.00
Upside/Downside57.48%
GradeFair
TypeBlend
Dividend Yield0.38%

Risk Assessment

Beta0.68
Volatility45.74%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.